Disentangling the central, peripheral, and haematological mechanisms of benefit of activin signaling inhibitor on exercise performance in pulmonary arterial hypertension

29 August 2026 (15:24 - 15:34)
Organised by: Logo
Congress Presentation Part of: Contextualising outcomes behind activin signaling inhibitor in pulmonary arterial hypertension Pulmonary Hypertension Open Access ESC Congress 2026 European Society of Cardiology